Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2026 · 10-Q
Revenue$613.23M$613.23M−10.1% vs Q2 2025 Net Income-$89.07M-$89.07MN/M vs Q2 2025 EPS Diluted-$1.16-$1.16N/M vs Q2 2025 Operating Income-$35,150,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$73,592,000N/M Margins · derivedOperating margin-5.7%+0.1 pt vs Q2 2025
Net margin-14.5%+112.9 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end